| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4K | — |
| Cost of Revenue | $2K | — |
| Gross Profit | $2K | — |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $148K | — |
| Operating Income | -$5.9M | — |
| Income Tax | $0 | — |
| Net Income | -$6.3M | -313.7% |
| EPS (Basic) | -$0.46 | — |
| EPS (Diluted) | -$0.46 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.2M | +366.8% |
| Inventory | $13K | -6.4% |
| Current Assets | $2.3M | +341.1% |
| Total Assets | $2.3M | -40.0% |
| Current Liabilities | $177K | -5.0% |
| Long-term Debt | $59K | — |
| Total Liabilities | $235K | +26.5% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.7M | — |
| Investing Cash Flow | $609K | — |
| Financing Cash Flow | $3.4M | — |
| $2.1M |
| -43.3% |